(Q35894998)
Statements
Increased lymphomagenicity and restored disease specificity of AML1 site (core) mutant SL3-3 murine leukemia virus by a second-site enhancer variant evolved in vivo (English)
murine leukemia virus
1 reference
Lovmand J
Schmidt J
Luz A
1 October 1997